The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mattingly Martin A since year 2005.
The trader's CIK number is 1265782.
At the time of this reporting, Mattingly Martin A is the Director of Sonus Pharmaceuticals Inc .
(stock ticker symbol SNUS).
See this page for all insider trading activities at Sonus Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-05-20||OGXI||Sonus Pharmaceuticals Inc||Option Ex||2,500||.00||0|
|2015-05-20||OGXI||Sonus Pharmaceuticals Inc||Option Ex||2,500||.00||0|
|2014-06-05||OGXI||Sonus Pharmaceuticals Inc||Option Ex||2,500||.00||0|
|2013-05-23||OGXI||Sonus Pharmaceuticals Inc||Option Ex||2,000||10.64||21,280|
|2012-06-01||OGXI||Sonus Pharmaceuticals Inc||Buy||1,000||12.46||12,460|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mattingly Martin A (Director of Sonus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.